<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref100">
 <mixed-citation publication-type="journal" id="cit100">
  <name>
   <surname>Liu</surname>
   <given-names>W.</given-names>
  </name>; 
  <name>
   <surname>Zhu</surname>
   <given-names>H. M.</given-names>
  </name>; 
  <name>
   <surname>Niu</surname>
   <given-names>G. J.</given-names>
  </name>; 
  <name>
   <surname>Shi</surname>
   <given-names>E. Z.</given-names>
  </name>; 
  <name>
   <surname>Chen</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Sun</surname>
   <given-names>B.</given-names>
  </name>; 
  <name>
   <surname>Chen</surname>
   <given-names>W. Q.</given-names>
  </name>; 
  <name>
   <surname>Zhou</surname>
   <given-names>H. G.</given-names>
  </name>; 
  <name>
   <surname>Yang</surname>
   <given-names>C.</given-names>
  </name>
  <article-title>Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors</article-title>. 
  <source>Bioorg. Med. Chem.</source>
  <year>2014</year>, 
  <volume>22</volume>, 
  <fpage>292</fpage>â€“
  <lpage>302</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.bmc.2013.11.028</pub-id>.
  <pub-id pub-id-type="pmid">24316352</pub-id>
 </mixed-citation>
</ref>
